Stephen Yoo

3.2k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Stephen Yoo is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephen Yoo has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephen Yoo's work include Cancer-related Molecular Pathways (4 papers), PARP inhibition in cancer therapy (4 papers) and Retinal Development and Disorders (3 papers). Stephen Yoo is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), PARP inhibition in cancer therapy (4 papers) and Retinal Development and Disorders (3 papers). Stephen Yoo collaborates with scholars based in United States, United Kingdom and Taiwan. Stephen Yoo's co-authors include Jeffrey C. Wang, Kenneth Kalunian, Victoria P. Werth, Joan T. Merrill, Richard Furie, Jörn Drappa, Philip Z. Brohawn, Munther A. Khamashta, Liangwei Wang and Gabor G. Illei and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Stephen Yoo

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

2016 618 citations Richard Furie, Munther A. Khamashta et al. Arthritis & Rheumatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Yoo United States	20	612	604	511	454	385	35	1.9k
Nancy Van Damme Belgium	23	357 0.6×	631 1.0×	363 0.7×	407 0.9×	300 0.8×	101	1.9k
Huaming Tan United States	25	1.1k 1.8×	575 1.0×	186 0.4×	550 1.2×	115 0.3×	54	2.4k
Mohammad K. Khan United States	30	373 0.6×	146 0.2×	432 0.8×	1.0k 2.3×	558 1.4×	121	2.5k
Wolfgang Schultze‐Seemann Germany	30	449 0.7×	323 0.5×	708 1.4×	523 1.2×	599 1.6×	89	2.5k
Stig Lenhoff Sweden	26	311 0.5×	107 0.2×	877 1.7×	1.0k 2.3×	114 0.3×	87	2.7k
Tomoyasu Kato Japan	27	186 0.3×	98 0.2×	986 1.9×	611 1.3×	132 0.3×	194	2.9k
Alexander J. Chou United States	25	223 0.4×	307 0.5×	931 1.8×	726 1.6×	99 0.3×	61	2.4k
Hannelore Denys Belgium	28	313 0.5×	122 0.2×	1.1k 2.2×	1.3k 2.9×	331 0.9×	148	3.1k
David B. Duggan United States	22	302 0.5×	153 0.3×	321 0.6×	1.4k 3.1×	341 0.9×	41	2.4k
Hubert Kübler Germany	31	631 1.0×	553 0.9×	654 1.3×	954 2.1×	1.5k 3.9×	131	4.4k

Countries citing papers authored by Stephen Yoo

Since Specialization

Citations

This map shows the geographic impact of Stephen Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Yoo more than expected).

Fields of papers citing papers by Stephen Yoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Yoo. The network helps show where Stephen Yoo may publish in the future.

Co-authorship network of co-authors of Stephen Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Yoo. A scholar is included among the top collaborators of Stephen Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Yoo. Stephen Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Andrew H, et al.. (2024). BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. Journal for ImmunoTherapy of Cancer. 12(3). e008303–e008303. 5 indexed citations

Sun, Linlin, Chia-Wei Li, Ezra M. Chung, et al.. (2020). Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. Cancer Research. 80(11). 2298–2310. 133 indexed citations

Peran, Ivana, Sivanesan Dakshanamurthy, Matthew McCoy, et al.. (2020). Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice. Gastroenterology. 160(4). 1359–1372.e13. 67 indexed citations

Ammar, Michael J., Katherine E. Uyhazi, Arkady Lyubarsky, et al.. (2018). Safety of the Subretinal Delivery of RGX-314 AAV8-anti-VEGF Fab Gene Therapy in NHP: Retinal Structure Over One Year. Investigative Ophthalmology & Visual Science. 59(9). 1422–1422. 2 indexed citations

Tretiakova, Anna, Tomás S. Alemán, Arkady Lyubarsky, et al.. (2017). Subretinal delivery of RGX-314 AAV8-anti-VEGF Fab gene therapy in NHP. Investigative Ophthalmology & Visual Science. 58(8). 4509–4509. 1 indexed citations

Liu, Yuanyuan, Seth D. Fortmann, Jikui Shen, et al.. (2017). AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration. Molecular Therapy. 26(2). 542–549. 40 indexed citations

Furie, Richard, Munther A. Khamashta, Joan T. Merrill, et al.. (2016). Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus. Arthritis & Rheumatology. 69(2). 376–386. 618 indexed citations breakdown →

Yoo, Stephen. (2015). Hemangiomas and vascular malformations of the GI tract. Seminars in Colon and Rectal Surgery. 26(2). 108–114. 1 indexed citations

Lin, Steven H., Jing Zhang, Uma Giri, et al.. (2014). A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(7). 965–973. 31 indexed citations

10.

Yoo, Stephen, Timothy J. Jorgensen, Ann R. Kennedy, et al.. (2014). Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development. Journal of Radiological Protection. 34(2). R25–R52. 146 indexed citations

11.

Cerna, David, et al.. (2012). Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity by Small Molecule GMX1778 Regulates Reactive Oxygen Species (ROS)-mediated Cytotoxicity in a p53- and Nicotinic Acid Phosphoribosyltransferase1 (NAPRT1)-dependent Manner. Journal of Biological Chemistry. 287(26). 22408–22417. 64 indexed citations

12.

Yoo, Stephen. (2011). GI-Associated Hemangiomas and Vascular Malformations. Clinics in Colon and Rectal Surgery. 24(3). 193–200. 42 indexed citations

13.

Ryan, Julie L., Sunil Krishnan, Benjamin Movsas, et al.. (2011). Decreasing the Adverse Effects of Cancer Therapy: An NCI Workshop on the Preclinical Development of Radiation Injury Mitigators/Protectors. Radiation Research. 176(5). 688–691. 20 indexed citations

14.

Cerna, David, et al.. (2010). Abstract 2506: Palomid 529, a PI3K/Akt/mTOR dual TORC1/2 inhibitor, is a radiosensitizer with effect in both subcutaneous and orthotopic U251 glioblastoma tumor xenograft models. Cancer Research. 70(8_Supplement). 2506–2506. 4 indexed citations

15.

Jobson, Andrew G., G.T. Lountos, Philip L. Lorenzi, et al.. (2009). Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. Journal of Pharmacology and Experimental Therapeutics. 331(3). 816–826. 81 indexed citations

16.

Yoo, Stephen, et al.. (2006). Erythrokeratoderma Variabilis Successfully Treated with Topical Tazarotene. Pediatric Dermatology. 23(4). 382–385. 6 indexed citations

17.

Wrone, David A., et al.. (2004). The Expression of p63 in Actinic Keratoses, Seborrheic Keratosis, and Cutaneous Squamous Cell Carcinomas. Dermatologic Surgery. 30(10). 1299–1302. 34 indexed citations

18.

Wang, Jeffrey C., et al.. (2003). EFFECT OF REGIONAL GENE THERAPY WITH BONE MORPHOGENETIC PROTEIN-2-PRODUCING BONE MARROW CELLS ON SPINAL FUSION IN RATS. Journal of Bone and Joint Surgery. 85(5). 905–911. 144 indexed citations

19.

Geck, Matthew J., Stephen Yoo, & Jeffrey C. Wang. (2001). Assessment of Cervical Ligamentous Injury in Trauma Patients Using MRI. Journal of Spinal Disorders. 14(5). 371–377. 25 indexed citations

20.

Wang, Jeffrey C., Stephen Yoo, & Rick B. Delamarter. (1999). The Publication Rates of Presentations at Major Spine Specialty Society Meetings (NASS, SRS, ISSLS). Spine. 24(5). 425–427. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact